L-DOPA methyl ester (hydrochloride)

CAS No. 1421-65-4

L-DOPA methyl ester (hydrochloride)( —— )

Catalog No. M20919 CAS No. 1421-65-4

L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 41 In Stock
200MG Get Quote In Stock
500MG 114 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-DOPA methyl ester (hydrochloride)
  • Note
    Research use only, not for human use.
  • Brief Description
    L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.
  • Description
    L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1421-65-4
  • Formula Weight
    247.7
  • Molecular Formula
    C10H14ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1.Cl
  • Chemical Name
    Alanine 3-(34-dihydroxyphenyl)- methyl ester hydrochloride l-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li R Liang T Chen Z et al. l-Dopa methyl ester attenuates amblyopia-induced neuronal injury in visual cortex of amblyopic cat[J]. Gene 2013 527(1):115-122.
molnova catalog
related products
  • BP14979

    BP14979 is a dopamine D3 receptor agonist that can be used to study neurological disorders.

  • CP-226269

    CP-226269 is a potent dopamine D4 receptor agonist that regulates calcium flux and has an EC50 value of 32.0 nM. CP 226269 can be used to study neurological disorders such as schizophrenia.

  • GSK598809

    GSK598809 (GSK-598809) is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.